NCT00525252View on ClinicalTrials.gov

Efficacy of Baclofen in the Treatment of Alcohol Addiction

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

86

Participants

Timeline

Start Date

February 28, 2003

Study Completion Date

November 30, 2006

Conditions
Liver Cirrhosis, Alcoholic
Interventions
DRUG

Baclofen

Baclofen orally administered for 12 consecutive weeks. For the first 3 days, baclofen administered at a dose of 5 milligrams 3 times per day; subsequently, the daily dose of baclofen will be increased to 10 milligrams 3 times per day.

DRUG

placebo

Placebo will be orally administered for 12 consecutive weeks

All Listed Sponsors
lead

Catholic University of the Sacred Heart

OTHER

NCT00525252 - Efficacy of Baclofen in the Treatment of Alcohol Addiction | Biotech Hunter | Biotech Hunter